Pages that link to "Q28595153"
Jump to navigation
Jump to search
The following pages link to Screening Bioactives Reveals Nanchangmycin as a Broad Spectrum Antiviral Active against Zika Virus (Q28595153):
Displaying 50 items.
- The Race To Find Antivirals for Zika Virus (Q29051492) (← links)
- Maternal-Fetal Transmission of Zika Virus: Routes and Signals for Infection (Q29451356) (← links)
- Advances in Developing Therapies to Combat Zika Virus: Current Knowledge and Future Perspectives (Q38156667) (← links)
- Current status of therapeutic and vaccine approaches against Zika virus (Q38156802) (← links)
- Organotypic models of type III interferon-mediated protection from Zika virus infections at the maternal-fetal interface (Q38156928) (← links)
- Gestational Stage and IFN-λ Signaling Regulate ZIKV Infection In Utero (Q40037502) (← links)
- Zika Virus: What Have We Learnt Since the Start of the Recent Epidemic? (Q40037723) (← links)
- Therapeutic Approaches for Zika Virus Infection of the Nervous System (Q41918254) (← links)
- Genome-wide mutagenesis of dengue virus reveals plasticity of the NS1 protein and enables generation of infectious tagged reporter viruses (Q41928809) (← links)
- Development of small-molecule viral inhibitors targeting various stages of the life cycle of emerging and re-emerging viruses (Q44106409) (← links)
- A Small-Molecule Oligosaccharyltransferase Inhibitor with Pan-flaviviral Activity (Q47280870) (← links)
- AXL promotes Zika virus infection in astrocytes by antagonizing type I interferon signalling (Q47548104) (← links)
- The antimalarial drug amodiaquine possesses anti-ZIKA virus activities. (Q47556542) (← links)
- Identification of novel small-molecule inhibitors of Zika virus infection (Q47558448) (← links)
- Human Placental Syncytiotrophoblasts Restrict Toxoplasma gondii Attachment and Replication and Respond to Infection by Producing Immunomodulatory Chemokines (Q48277104) (← links)
- Infection by Zika viruses requires the transmembrane protein AXL, endocytosis and low pH. (Q51336052) (← links)
- Topical application of aminoglycoside antibiotics enhances host resistance to viral infections in a microbiota-independent manner. (Q52597757) (← links)
- A Review of the Ongoing Research on Zika Virus Treatment. (Q53682362) (← links)
- Flaviviridae virus nonstructural proteins 5 and 5A mediate viral immune evasion and are promising targets in drug development. (Q54111285) (← links)
- Flavivirus internalization is regulated by a size-dependent endocytic pathway. (Q54243187) (← links)
- The Flavonoid Isoquercitrin Precludes Initiation of Zika Virus Infection in Human Cells. (Q54986369) (← links)
- Zika virus, vaccines and antiviral strategies. (Q55084364) (← links)
- Host-Directed Antivirals: A Realistic Alternative to Fight Zika Virus (Q56337984) (← links)
- Potential targets for therapeutic intervention and structure based vaccine design against Zika virus (Q56341811) (← links)
- Inflammation-Induced, STING-Dependent Autophagy Restricts Zika Virus Infection in the Drosophila Brain (Q56347747) (← links)
- Species-specific disruption of STING-dependent antiviral cellular defenses by the Zika virus NS2B3 protease (Q56349500) (← links)
- The A-Z of Zika drug discovery (Q56353961) (← links)
- The celecoxib derivative kinase inhibitor AR-12 (OSU-03012) inhibits Zika virus via down-regulation of the PI3K/Akt pathway and protects Zika virus-infected A129 mice: A host-targeting treatment strategy (Q57467989) (← links)
- Research Models and Tools for the Identification of Antivirals and Therapeutics against Zika Virus Infection (Q58099567) (← links)
- Potent suppression of HIV-1 cell attachment by Kudzu root extract (Q58711298) (← links)
- Investigational drugs for the treatment of Zika virus infection: a preclinical and clinical update (Q59245664) (← links)
- Cellular Targets for the Treatment of Flavivirus Infections (Q59329458) (← links)
- Secondary Metabolites of Actinomycetes and their Antibacterial, Antifungal and Antiviral Properties (Q59350641) (← links)
- Drug Repurposing for Viral Infectious Diseases: How Far Are We? (Q59360930) (← links)
- Mechanism of action of methotrexate against Zika virus (Q60173780) (← links)
- Zika Virus: Origins, Pathological Action, and Treatment Strategies (Q60919470) (← links)
- ZIKA virus entry mechanisms in human cells (Q61053671) (← links)
- Benzoxazine monomer derived carbon dots as a broad-spectrum agent to block viral infectivity (Q61795544) (← links)
- Advances in Zika Virus⁻Host Cell Interaction: Current Knowledge and Future Perspectives (Q62485332) (← links)
- Identification of antiviral roles for the exon-junction complex and nonsense-mediated decay in flaviviral infection (Q62485353) (← links)
- Zika outbreak aftermath: status, progress, concerns and new insights (Q62756577) (← links)
- Mechanism of Action of Methotrexate Against Zika Virus (Q63248462) (← links)
- Discovery, Optimization, and Target Identification of Novel Potent Broad-Spectrum Antiviral Inhibitors (Q63248505) (← links)
- Anti-Zika Activity of a Library of Synthetic Carbohydrate Receptors (Q63248516) (← links)
- Cytochrome P450 Monooxygenase CYP139 Family Involved in the Synthesis of Secondary Metabolites in 824 Mycobacterial Species (Q66679865) (← links)
- High-Throughput Screening Identifies Mixed-Lineage Kinase 3 as a Key Host Regulatory Factor in Zika Virus Infection (Q67087239) (← links)
- Discovery and development of safe-in-man broad-spectrum antiviral agents (Q88486719) (← links)
- Streptomyces species: Ideal chassis for natural product discovery and overproduction (Q88934294) (← links)
- New avenues for therapeutic discovery against West Nile virus (Q89526672) (← links)
- Montelukast, an Anti-asthmatic Drug, Inhibits Zika Virus Infection by Disrupting Viral Integrity (Q89820495) (← links)